Theme: Exploring Latest Trends in Pharmacovigilance and Clinical Trials in the era of COVID-19
Renowned Speakers
Mayada AlkhakanySenior Global NTA Manager, Boehringer Ingelheim
Germany
Eliana Silva de MoraesPresident Brazilian Regulatory Affairs
France
Antonio Steardopharmaceutical and professional consultant,
Italy
KHAUDEJA BANOEXECUTIVE MEDICAL DIRECTOR, COMBINATION PRODUCT SAFETY HEAD GLOBAL PATIENT SAFETY & PEDIATRICS AMGEN,
USA
Robert MassouhDirector - Risk Management Product Lead at Pfizer,
UK
Dr. Ilke SipahiDepartment of Cardiology, Acibadem University Medical School, Istanbul,
Turkey
MINHONG CHOA Yonsei University
South Korea
Manal YounusHead of Iraqi Pharmacovigilance Center, MOH. ISoP Advisory Board Member, CIOMS Executive Board Member, ISoP Middle East Chapter Vice President
Iraq
Aaron Damien BarzeyAssociate Director, Scientific Support Galapagos
UK
Rimma BattalovaQPPV Arterium Corporation Kyiv
Ukraine
Joan D’souzaRegulatory Medical Writer/ Pharmacovigilance/Juris Doctor/ ISoP Chair for Switzerland and Austria/ EMWA volunteer
Switzerland
Loreta AdomonytePharmacovigilance Manager, EduPharma,
Lithuania